Norris Medicines Limited primarily engages in the manufacture of pharmaceutical formulations in India. It offers products in the fields of antibiotic, anti-inflammatory-pain management, analgesic, gastrointestinal, dermatological, nutrition, anti-malarial, anti-emetic, cough/cold, dental, diabetic, and cardiac, as well as other fields in various formulations, including tablets, capsules, liquid orals, and copical ointments. The company also offers contract and loan license manufacturing services. In addition, it exports its products to European countries, Middle East, Far East, and African countries. The company was incorporated in 1990 and is based in Ankleshwar, India.
Metrics to compare | NORI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNORIPeersSector | |
---|---|---|---|---|
P/E Ratio | −15.2x | 11.0x | −0.5x | |
PEG Ratio | 3.62 | 0.11 | 0.00 | |
Price/Book | −1.3x | 1.1x | 2.6x | |
Price / LTM Sales | 3.2x | 1.1x | 3.0x | |
Upside (Analyst Target) | - | 0.0% | 52.5% | |
Fair Value Upside | Unlock | 9.0% | 8.7% | Unlock |